Indian Liraglutide Exporters: Complete Supplier Ranking with Market Share — 121 Manufacturers (2026) — TransData Nexus

Q: Who is the largest liraglutide buyer importing from India?

YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the largest liraglutide importer from India with a 52.6% market share and import value of $2.3M.

Q: How many liraglutide buyers import from India?

There are 121 active liraglutide buyers importing from India, with a combined import market of $4.3M across 416 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top liraglutide buyers from India?

The top 5 liraglutide buyers — YUSEN LOGISTICS BENELUX BELGIUM, M/S MEDPRO PHARMACEUTICA PTY LTD, SUCCEED HOLDINGS LTD., DR,ANTHONY ANDRE,, PHARMACHEM PRIVATE LIMITED — together control 93.9% of total liraglutide import value from India.

Suresh Sormare

Liraglutide

India Pharmaceutical Trade Intelligence

$4.3M53 Suppliers36 CountriesHS 30049099

ExportsIndia → BELGIUM52.7%India → SOUTH AFRICA32.6%

ImportsDENMARK → India$157.8M GREECE → India$1.4M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Market Analysis: Top Importing Countries & Their Importers

1Belgium

Belgium emerges as the first largest importing country, achieving a total trade value of $2.3M through 7 shipments. This represents a market share of 52.7% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Belgium has a diverse importer base, with their top importers including:

• YUSEN LOGISTICS BENELUX BELGIUM - $2.3M (99.9% of country's total business)

Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $321.9K, indicating premium pricing strategy compared to the market average of $10.3K.

Belgium is a key market for Liraglutide imports, representing 52.7% of total trade value.

Primary Market

Secondary Market

2South Africa

South Africa emerges as the second largest importing country, achieving a total trade value of $1.4M through 3 shipments. This represents a market share of 32.6% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Liraglutide buyer market intelligence

1Buyer Segment Analysis

Our data indicates that Liraglutide exports from India amounted to $4.3 million across 416 shipments, involving 53 exporters and 121 buyers across 36 importing countries. The repeat buyer rate stands at 58.7%, suggesting a stable demand base.

Buyer Segments:

1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $2.25M) and M/S MEDPRO PHARMACEUTICA PTY LTD (South Africa, $1.40M) fall into this category. These distributors typically procure large volumes to supply regional markets, ensuring consistent availability to healthcare providers. Their order patterns are characterized by bulk purchases aligned with market demand forecasts.

2. Re-exporters: SUCCEED HOLDINGS LTD. (Hong Kong, $0.32M) exemplifies this segment. Operating in strategic trade hubs, re-exporters import Liraglutide for redistribution to neighboring regions, leveraging favorable trade agreements and logistical advantages. Their purchasing behavior is influenced by regional demand fluctuations and trade policies.

3. Healthcare Providers: Entities such as DR. ANTHONY ANDRE (United States, $0.03M) and PHARMACHEM PRIVATE LIMITED (Nepal, $0.02M) represent direct procurement by healthcare professionals or institutions. Their orders are typically smaller and more frequent, driven by immediate patient needs and inventory management practices.

4. Contract Manufacturers: CHEMO LABORATORIOS LICONSA, S.A (Spain, $0.01M) and CIPLA BRASIL IMPORTADORA E DISTRIBU (Brazil, $0.01M) may act as contract manufacturers, importing Liraglutide for formulation and packaging under specific brand names. Their procurement is project-based, aligning with production schedules and contractual obligations.

Understanding these segments is crucial for tailoring marketing strategies, optimizing supply chains, and identifying potential growth opportunities in the Liraglutide market.

Country-Specific Import Regulations

TransData Nexus Liraglutide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries—Belgium, South Africa, Hong Kong, Saudi Arabia, and the United States—importing Liraglutide involves navigating specific regulatory frameworks:

1. Belgium:

Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

Import Registration Process: Importers must obtain a marketing authorization from FAMHP, demonstrating compliance with EU Good Manufacturing Practices (GMP).

Estimated Timeline: The registration process typically takes 12 to 18 months, depending on the completeness of the dossier and any additional requirements.

Import Tariff/Duty: As an EU member, Belgium applies a common external tariff; however, pharmaceutical products under HS Code 30049099 are often exempt from import duties.

2. South Africa:

Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).

Demand Drivers & Market Opportunity

TransData Nexus Liraglutide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Liraglutide is primarily driven by the global prevalence of type 2 diabetes and obesity. According to the World Health Organization (WHO), over 1 billion people worldwide are affected by obesity, with type 2 diabetes being a significant comorbidity. In September 2025, the WHO added GLP-1 receptor agonists, including Liraglutide, to its Model List of Essential Medicines, underscoring their importance in managing these conditions.

Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries incorporate essential medicines into their public health initiatives, facilitating broader access through subsidized programs and national tenders. The inclusion of Liraglutide in the WHO Essential Medicines List enhances its procurement through international and national tender-based purchasing systems, ensuring availability in public healthcare settings. Our data, indicating 121 buyers across 36 countries, reflects this widespread adoption and the growing recognition of Liraglutide's therapeutic value.

In summary, the combination of high disease prevalence, supportive healthcare policies, and strategic procurement mechanisms positions Liraglutide as a critical component in the global fight against type 2 diabetes and obesity, presenting substantial market opportunities for stakeholders.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Liraglutide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest liraglutide buyer importing from India?

Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $2.3M in imports and a 52.6% market share — the highest of any single liraglutide importer. M/S MEDPRO PHARMACEUTICA PTY LTD (SOUTH AFRICA) and SUCCEED HOLDINGS LTD. (HONG KONG) are the next largest buyers.

QHow many companies buy liraglutide from India?

There are 121 active liraglutide buyers importing from India, with a combined market of $4.3M across 416 shipments to 36 countries. The top 5 buyers hold 93.9% of total import value, while the remaining 116 buyers handle the other 6.1%.

QWhich countries import the most liraglutide from India?

The top importing countries for liraglutide from India are Belgium (52.7%), South Africa (32.6%), Hong Kong (7.6%), Saudi Arabia (3.6%), United States (0.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of liraglutide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for liraglutide from India?

The average import transaction value for liraglutide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Liraglutide buyer market intelligence

1Buyer Segment Analysis

Buyer Segments:

Understanding these segments is crucial for tailoring marketing strategies, optimizing supply chains, and identifying potential growth opportunities in the Liraglutide market.

Country-Specific Import Regulations

TransData Nexus Liraglutide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries—Belgium, South Africa, Hong Kong, Saudi Arabia, and the United States—importing Liraglutide involves navigating specific regulatory frameworks:

1. Belgium:

Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

Import Registration Process: Importers must obtain a marketing authorization from FAMHP, demonstrating compliance with EU Good Manufacturing Practices (GMP).

Estimated Timeline: The registration process typically takes 12 to 18 months, depending on the completeness of the dossier and any additional requirements.

Import Tariff/Duty: As an EU member, Belgium applies a common external tariff; however, pharmaceutical products under HS Code 30049099 are often exempt from import duties.

2. South Africa:

Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).

Demand Drivers & Market Opportunity

TransData Nexus Liraglutide buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Liraglutide

Liraglutide

Who Buys Liraglutide from India — 121 Importers Behind a $4.3M Market

Top Liraglutide Importers — Ranked by Import Value

Top Liraglutide Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Liraglutide — and from which countries?

Liraglutide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Belgium

2South Africa

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Liraglutide Buyers & Importers

QWho is the largest liraglutide buyer importing from India?

QHow many companies buy liraglutide from India?

QWhich countries import the most liraglutide from India?

QWhat is the average import order value for liraglutide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Hong Kong

4Saudi Arabia

5United States

Analysis Methodology